Home/Filings/4/0000950170-25-024337
4//SEC Filing

Sims Andrew John Hugh MacIntyre 4

Accession 0000950170-25-024337

CIK 0001095981other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 5:30 PM ET

Size

5.5 KB

Accession

0000950170-25-024337

Insider Transaction Report

Form 4
Period: 2025-02-18
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-18+60,02060,020 total
    Exercise: $1.18Exp: 2035-02-17Common Stock (60,020 underlying)
Footnotes (1)
  • [F1](1) The option vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Documents

1 file

Issuer

PLUS THERAPEUTICS, INC.

CIK 0001095981

Entity typeother

Related Parties

1
  • filerCIK 0001802687

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 5:30 PM ET
Size
5.5 KB